Scott Sandler

Vice President
Pharmaceuticals
Oxford BioTherapeutics
Switzerland

Business Expert Pharmaceutical Sciences
Biography

 Mr Sandler brings over 20 years of financial experience in the biotechnology industry to OBT. Most recently, he was Senior Director at Hyperion Therapeutics, a pharmaceutical company focussed on therapies for orphan diseases. Previously, he has held financial roles at Ipsen, Nektar Therapeutics and Genentech. Mr. Sandler holds an BSE in engineering from Tufts University and an MBA from the University of Michigan.

Research Intrest

 Genetics

Global Scientific Words in Pharmaceutical Sciences